We further report differential CSF levels of ChAT in relation to Alzheimer’s disease risk genotypes, as well as in patients with multiple sclerosis, a chronic neuroinflammatory disease, compared to controls. This evidence concerns the gene CHAT and early-onset autosomal dominant Alzheimer disease.